T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$2.57B |
| 2 |
GE Aerospace
GE
|
+$1.8B |
| 3 |
UnitedHealth
UNH
|
+$1.63B |
| 4 |
Marriott International
MAR
|
+$1.62B |
| 5 |
Apple
AAPL
|
+$1.3B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$2.87B |
| 2 |
JPMorgan Chase
JPM
|
+$1.64B |
| 3 |
Nike
NKE
|
+$1.59B |
| 4 |
Becton Dickinson
BDX
|
+$1.46B |
| 5 |
Alibaba
BABA
|
+$1.32B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.47% |
| 2 | Healthcare | 18.68% |
| 3 | Consumer Discretionary | 13.32% |
| 4 | Financials | 12.13% |
| 5 | Communication Services | 10.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Williams-Sonoma
WSM
$28.9B
| $6.17M | ﹤0.01% |
290,100
-3,568
| -1% | -$113K |
|
1302
Rigel Pharmaceuticals
RIGL
$762M
| $6.15M | ﹤0.01% |
393,987
+11,346
| +3% | +$242K |
|
|
PROS
1303
DELISTED
ProSight Global, Inc.
PROS
| $6.11M | ﹤0.01% |
626,829
-98,120
| -14% | -$1.35M |
|
1304
Harley-Davidson
HOG
$2.7B
| $6.09M | ﹤0.01% |
321,820
+21,806
| +7% | +$660K |
|
1305
RB Global
RBA
$16B
| $6.07M | ﹤0.01% |
177,639
+11,652
| +7% | +$466K |
|
1306
Sprott Physical Gold
PHYS
$15.7B
| $6.04M | ﹤0.01% |
+460,500
| New | +$5.86M |
|
|
OPLN
1307
Openlane
OPLN
$4.34B
| $6.02M | ﹤0.01% |
501,875
+4,182
| +0.8% | +$81.7K |
|
1308
Blackstone Mortgage Trust
BXMT
$2.41B
| $5.93M | ﹤0.01% |
318,647
+267,382
| +522% | +$9.08M |
|
1309
Roku
ROKU
$22.9B
| $5.88M | ﹤0.01% |
67,277
+15,307
| +29% | +$1.76M |
|
1310
Liberty Global Class C
LBTYK
$3.46B
| $5.88M | ﹤0.01% |
374,420
+66,732
| +22% | +$1.25M |
|
1311
Avient
AVNT
$4.16B
| $5.84M | ﹤0.01% |
307,780
-1,880,898
| -86% | -$52.6M |
|
1312
TIM SA
TIMB
$8.69B
| $5.81M | ﹤0.01% |
478,084
-39,346
| -8% | -$700K |
|
1313
Chegg
CHGG
$89.3M
| $5.81M | ﹤0.01% |
162,472
-1,139,126
| -88% | -$44.5M |
|
1314
Sprott Physical Gold and Silver Trust
CEF
$8.17B
| $5.81M | ﹤0.01% |
397,140
-109,789
| -22% | -$1.64M |
|
1315
Valvoline
VVV
$4.25B
| $5.8M | ﹤0.01% |
442,872
-7,502,754
| -94% | -$144M |
|
1316
Minerva Neurosciences
NERV
$187M
| $5.78M | ﹤0.01% |
120,076
-34,523
| -22% | -$2.08M |
|
|
REVG
1317
DELISTED
REV Group
REVG
| $5.78M | ﹤0.01% |
1,386,608
-342,125
| -20% | -$3M |
|
1318
iShares Core US Aggregate Bond ETF
AGG
$138B
| $5.78M | ﹤0.01% |
+50,100
| New | +$5.71M |
|
1319
Arvinas
ARVN
$580M
| $5.75M | ﹤0.01% |
142,799
+117,548
| +466% | +$5.5M |
|
1320
H&R Block
HRB
$6.76B
| $5.75M | ﹤0.01% |
408,343
+26,177
| +7% | +$548K |
|
|
NBL
1321
DELISTED
Noble Energy, Inc.
NBL
| $5.74M | ﹤0.01% |
949,713
-5,533,113
| -85% | -$88.8M |
|
1322
Petrobras
PBR
$115B
| $5.66M | ﹤0.01% |
+1,028,952
| New | +$12.3M |
|
1323
NNN REIT
NNN
$8.79B
| $5.65M | ﹤0.01% |
175,606
+14,532
| +9% | +$730K |
|
1324
The RealReal
REAL
$1.33B
| $5.63M | ﹤0.01% |
802,530
+365,622
| +84% | +$4.98M |
|
1325
Sonos
SONO
$1.86B
| $5.61M | ﹤0.01% |
+661,281
| New | +$8.17M |
|
Similar funds
T. Rowe Price Associates's Q1 2020 Portfolio in Review
As of Q1 2020, T. Rowe Price Associates held 2,612 positions worth $632B, down 18% from $771B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2020 filing shows 87 new, 1,525 increased, 823 reduced and 103 closed positions. Its largest new stake was Philips: 33,363,001 shares worth $1.07B. The largest sale was Boeing, an estimated $2.87B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2020 buy was Philips: 33,363,001 shares worth $1.07B.
- T. Rowe Price Associates added most to Humana in Q1 2020, an estimated $2.57B increase.
- T. Rowe Price Associates's biggest Q1 2020 reduction was Boeing, cutting an estimated $2.87B.
- T. Rowe Price Associates fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $846M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $632B portfolio in Q1 2020.
- T. Rowe Price Associates opened 87 new positions and closed 103 in Q1 2020.
- T. Rowe Price Associates's portfolio value fell 18% quarter-over-quarter to $632B.
Based on T. Rowe Price Associates's 13F filing for Q1 2020, filed 15 May 2020.